As of November 2019 , 55 percent of clinical trials in cell and gene therapy development were in phase two , and 30 percent were in phase one of clinical trials . This statistic shows the proportion of clinical trials for cell and gene therapies worldwide as of late-2019 , by clinical trial phase .
